In recent times, Silicon Valley tech companies and venture capital (VC) funds have banded together to transform healthcare. This has lead to the creation of a new type of industry that includes digital health services, digital therapeutics, and even digital medicines. But don’t get sucked into the hype — the digital healthcare space has its own challenges and 2020 might be the year of reckoning for many companies.
A lot of money but little to show for
Since the first iPhones rolled out, developers were quick to release all sorts of health apps that monitor various factors, including weight, exercise, blood pressure, cholesterol levels, sugar levels, heart rate and sleep quality. Some apps even claim that they detect cancer.
Today, there are roughly 318,000 health-related apps available on the market and almost 20% of smartphone users have one or more applications on their device that help them track or manage their health.
The year 2019 saw a lot of money pouring into startups and many digital health unicorns (valued at over $1 billion) were created overnight with high-flying initial public offerings (IPOs).
VC funding leveled off to about $7 billion in 2019 after topping at $8 billion the prior year with over 350 companies funded. That same year, six companies had IPOs resulting in a combined market value of $17 billion, among them Livongo, Change Healthcare, Phreesia, and Health Catalyst. By 2026, the global digitalization healthcare market value is expected to reach around $511 billion.
Digital healthcare is booming -- but who will come out on top?:
No comments:
Post a Comment